KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
90 hedge funds and large institutions have $375M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+8
Holders Change %
+9.76%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
17
Increased
38
Reduced
20
Closed
9
Calls
$674K
Puts
$109K
Net Calls
+$565K
Net Calls Change
-$121K
Top Buyers
| 1 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
+$69.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.96M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.63M |
| 4 |
BlackRock
New York
|
+$2.85M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.7M |
Top Sellers
| 1 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$2.65M |
| 2 |
NC
Nexthera Capital
New York
|
-$1.77M |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$1.25M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$1.23M |
| 5 |
Jennison Associates
New York
|
-$909K |
